Nevus, Pigmented  >>  Imlygic (talimogene laherparepvec)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Imlygic (talimogene laherparepvec) / Amgen
NCT00289016 / 2006-003841-17: A Study of Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant Melanoma

Completed
2
50
US, Europe
Talimogene Laherparepvec, OncoVEX^GM-CSF, T-VEC, IMLYGIC
BioVex Limited, Symbion Research International
Melanoma
12/08
05/09

Download Options